Result
The number of patients with Parkinson's Disease for the analysis was 4,137, and that of claims cases for 12 months was 19,551. The average age of the patients was 71.3 years old and the female patients composed of 60.14%, which was about 1.5 times that of the male patients. The prevalence rate of Parkinson's Disease per 1,000 populations was 3.28 in 2013. Based on 1-year claims dataset, annual average visit days of outpatients were 6.8 and annual average days of inpatient hospitalization were 119.02. The annual average of direct medical costs was USD 950 for an outpatient and USD 9,790 for an inpatient (Exchange rate : 1 USD = 1,000 KRW) 2 .
Background / Objectives
Parkinson's Disease is the second most common neurodegenerative disorder after Alzheimer's disease and is expected to impose an increasing social and economic burden on societies as populations age 1 . However, there are only few studies about analysis of the relevant medical costs of Parkinson's disease in Korea. The research is to analyze social demographic characteristics and nature of health services use of Parkinson's Disease in Korea and this is done by using Korean National Health Insurance Claims dataset (HIRA-NPS 2013), which is one of the secondary sources of health and medical treatment provided by the reimbursement authorities. The research also serves to measure direct medical costs of Parkinson's Disease.
Conclusion
According to the result, 119. 02 days of average hospitalization days for the Parkinson's Disease are much higher than 14.6 days of average hospitalization days from Patient report in 2013 3 . It shows that the Parkinson's Disease causes significant economic burden in Korea. The limitation that the sample data used for the research is smaller than the raw data should be considered. Direct medical costs could also be higher than the results because the National Health Insurance Claims Dataset doesn't include patient out-of-pocket payments 4 . Therefore further analysis on Parkinson's Disease in aging society is critical to understand the exact implications of the disease.
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